Revenue rose 8.5% year-on-year to ₹445.4 crore from ₹410.6 crore. Operating performance strengthened, with EBITDA coming in at ₹31.5 crore, nearly tripling from ₹12 crore a year ago.
EBITDA margins expanded to 7.1% from 2.9% in the year-ago quarter.
Shares of Indoco Remedies were reacting positively to the improved operating metrics and were trading around 9.38% higher in trade today.
/images/ppid_59c68470-image-177010256285886601.webp)

/images/ppid_59c68470-image-177010259560749346.webp)
/images/ppid_59c68470-image-17701026566624315.webp)
/images/ppid_59c68470-image-177010253235918152.webp)
/images/ppid_59c68470-image-177010269131716416.webp)
/images/ppid_59c68470-image-177010254013942982.webp)
/images/ppid_59c68470-image-177010256228532734.webp)
/images/ppid_59c68470-image-1770102527416450.webp)
/images/ppid_59c68470-image-177010252743766110.webp)